Elanco Animal Health ELAN
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: +$20.07M (9 inflow days, 11 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 49.1% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 5.95% to 6.59% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| FMR | Mutual Fund | 2026/Q3 | +9,757,826 | 11.9% |
| Artemis Investment Management LLP | Mutual Fund | 2026/Q3 | +1,645,331 | 0.9% |
| Wilshire Advisors LLC | Mutual Fund | 2026/Q3 | +1,144,784 | 0.2% |
| Jupiter Fund Management Plc | Mutual Fund | 2026/Q3 | +850,405 | 1.0% |
| Bowen, Hanes & Company, Inc. | Mutual Fund | 2026/Q3 | +797,945 | 0.7% |
| Voya Investment Management LLC | Mutual Fund | 2026/Q3 | +784,974 | 0.2% |
| Thrivent Investment Management, Inc. | Mutual Fund | 2026/Q3 | +542,529 | 0.3% |
| Citadel Advisors LLC | Hedge Fund | 2026/Q3 | +5,281,484 | 1.9% |
| FMR | Mutual Fund | 2026/Q3 | +3,394,229 | 9.9% |
| Marshall Wace LLP | Hedge Fund | 2026/Q3 | +3,049,938 | 0.9% |
| Morgan Stanley | Public Company | 2026/Q3 | +2,733,843 | 1.1% |
| Strategic Advisers LLC | Mutual Fund | 2026/Q3 | +2,629,224 | 1.5% |
| Black Creek Investment Management Inc. | Mutual Fund | 2026/Q3 | +2,552,571 | 2.6% |
| Freestone Grove Partners LP | Hedge Fund | 2026/Q3 | +2,170,681 | 0.4% |
| Manulife Asset Management | Mutual Fund | 2026/Q3 | +2,126,727 | 1.7% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 29 Oct 2026 | Jeffrey Simmons | Chief Executive Officer | Other Derivative Acquisition | +122 | – | 25,742 |
| 29 Oct 2026 | Robert VanHimbergen | Chief Financial Officer | Other Derivative Acquisition | +8 | – | 184 |
| 29 Oct 2026 | Rajeev Modi | Executive Vice President of U.S. Pet Health & Global Digital Transformation | Other Derivative Acquisition | +64 | – | 10,090 |
| 15 Oct 2026 | Jeffrey Simmons | Chief Executive Officer | Other Derivative Acquisition | +120 | – | 25,619 |
| 15 Oct 2026 | Robert VanHimbergen | Chief Financial Officer | Other Derivative Acquisition | +8 | – | 176 |
| 15 Oct 2026 | Rajeev Modi | Executive Vice President of U.S. Pet Health & Global Digital Transformation | Other Derivative Acquisition | +62 | – | 10,026 |
| 14 Oct 2026 | Timothy Bettington | Executive Vice President of Center of Strategic Growth | Automatic Disposition | -4,350 | $23.00 | 101,532 |
| 14 Oct 2026 | Timothy Bettington | Executive Vice President of Center of Strategic Growth | Intent to Sell (Form 144) | -4,350 | $23.00 | – |
| 1 Oct 2026 | Jeffrey Simmons | Chief Executive Officer | Other Derivative Acquisition | +127 | – | 25,499 |
| 1 Oct 2026 | Robert VanHimbergen | Chief Financial Officer | Other Derivative Acquisition | +8 | – | 168 |
| 1 Oct 2026 | Rajeev Modi | Executive Vice President of U.S. Pet Health & Global Digital Transformation | Other Derivative Acquisition | +66 | – | 9,963 |
| 29 Sep 2026 | Kapila Anand | Independent Director | Other Derivative Acquisition | +642 | – | 10,722 |
| 17 Sep 2026 | Jeffrey Simmons | Chief Executive Officer | Other Derivative Acquisition | +126 | – | 25,372 |
| 17 Sep 2026 | Robert VanHimbergen | Chief Financial Officer | Other Derivative Acquisition | +8 | – | 159 |
| 17 Sep 2026 | Rajeev Modi | Executive Vice President of U.S. Pet Health & Global Digital Transformation | Other Derivative Acquisition | +65 | – | 9,896 |
| 3 Sep 2026 | Jeffrey Simmons | Chief Executive Officer | Other Derivative Acquisition | +115 | – | 25,246 |
| 3 Sep 2026 | Robert VanHimbergen | Chief Financial Officer | Other Derivative Acquisition | +8 | – | 150 |
| 3 Sep 2026 | Rajeev Modi | Executive Vice President of U.S. Pet Health & Global Digital Transformation | Other Derivative Acquisition | +60 | – | 9,831 |
| 20 Aug 2026 | Jeffrey Simmons | Chief Executive Officer | Other Derivative Acquisition | +117 | – | 25,130 |
| 20 Aug 2026 | Robert VanHimbergen | Chief Financial Officer | Other Derivative Acquisition | +8 | – | 142 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 32,923,699 | 6.6% | 7.2 |
| 15 Oct 2026 | 31,106,655 | 6.2% | 6.4 |
| 30 Sep 2026 | 37,291,528 | 7.5% | 6.2 |
| 15 Sep 2026 | 31,809,151 | 6.4% | 6.3 |
| 31 Aug 2026 | 30,920,811 | 6.2% | 6.4 |
| 14 Aug 2026 | 29,719,014 | 5.9% | 2.5 |
No comments yet — be the first to weigh in on ELAN.
Sign in to join the discussion.